These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25270397)

  • 1. Telmisartan treatment of refractory proteinuria in a dog.
    Bugbee AC; Coleman AE; Wang A; Woolcock AD; Brown SA
    J Vet Intern Med; 2014; 28(6):1871-4. PubMed ID: 25270397
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteinuria in an African HIV-infected patient: effects of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Pizzigallo E; Vecchiet J
    Infez Med; 2011 Jun; 19(2):125-7. PubMed ID: 21753253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.
    Bichu P; Nistala R; Khan A; Sowers JR; Whaley-Connell A
    Vasc Health Risk Manag; 2009; 5(1):129-40. PubMed ID: 19436679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
    Mann JF; Schmieder RE; McQueen M; Dyal L; Schumacher H; Pogue J; Wang X; Maggioni A; Budaj A; Chaithiraphan S; Dickstein K; Keltai M; Metsärinne K; Oto A; Parkhomenko A; Piegas LS; Svendsen TL; Teo KK; Yusuf S;
    Lancet; 2008 Aug; 372(9638):547-53. PubMed ID: 18707986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.
    Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Aug; 167(4):1443-9. PubMed ID: 22560941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria: Is the ONTARGET renal substudy actually off target?
    Ruggenenti P; Remuzzi G
    Nat Rev Nephrol; 2009 Aug; 5(8):436-7. PubMed ID: 19639016
    [No Abstract]   [Full Text] [Related]  

  • 9. Renoprotective effect of telmisartan in patients with chronic kidney disease.
    Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Node K
    Clin Exp Hypertens; 2008 Oct; 30(7):662-72. PubMed ID: 18855269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan in incipient and overt diabetic renal disease.
    Schmieder RE; Bakris G; Weir MR
    J Nephrol; 2011; 24(3):263-73. PubMed ID: 21374585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan did not prevent renal disease in patients without proteinuria.
    Ann Intern Med; 2009 Jul; 151(1):I28. PubMed ID: 19451555
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
    J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(1):45-6. PubMed ID: 21298207
    [No Abstract]   [Full Text] [Related]  

  • 15. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S
    J Int Med Res; 2005; 33(6):677-86. PubMed ID: 16372586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II receptor blockers on diabetic nephropathy.
    Kalaitzidis R; Bakris GL
    J Hypertens Suppl; 2009 Jul; 27(5):S15-21. PubMed ID: 19587550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
    Bakris G; Burgess E; Weir M; Davidai G; Koval S;
    Kidney Int; 2008 Aug; 74(3):364-9. PubMed ID: 18496508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).
    Pecci A; Granata A; Fiore CE; Balduini CL
    Nephrol Dial Transplant; 2008 Aug; 23(8):2690-2. PubMed ID: 18503011
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
    Masuda S; Tamura K; Wakui H; Kanaoka T; Ohsawa M; Maeda A; Dejima T; Yanagi M; Azuma K; Umemura S
    Hypertens Res; 2009 Nov; 32(11):950-5. PubMed ID: 19713965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan in the management of diabetic nephropathy: a contemporary view.
    Balakumar P; Bishnoi HK; Mahadevan N
    Curr Diabetes Rev; 2012 May; 8(3):183-90. PubMed ID: 22429010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.